Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
27.01.Astoriom Acquires Precision Stability Storage
27.01.VoxCell Appoints Graham Craig as Chief Commercial Officer
27.01.Evestia Clinical Acquires ICRC-Weyer
26.01.Eurofins CDMO Alphora to Launch AI-Powered Software for High-Throughput Screening
26.01.Fortitude Biomedicines Launches, Will Advance Treatments for Autoimmune Diseases and Cancer
26.01.MS Pharma Group, Hetero Group Partner to Localize Biosimilars in MENA Region
26.01.Recipharm Expands Manufacturing in Support of FDA Guidance
26.01.Eclipsebio Acquires Terrain Bio
26.01.Janux Therapeutics Taps Dr. William Go as Chief Medical Officer
23.01.Coating Place Names Ajay Damani President in Round of Leadership Appointments
23.01.SK Bioscience to Support CEPI-Backed Development of Updated Zaire Ebolavirus Vaccine
22.01.Janux Therapeutics Pairs With BMS on Novel Tumor-Activated Therapeutic
22.01.Cellular Origins, Fresenius Kabi Tout Automation Milestone in Scaling CGT Manufacturing
22.01.Gannet BioChem Acquires Laysan Bio
22.01.Rentschler Biopharma Taps Detra Glinatsis as Head of Business Development U.S.
21.01.Datwyler Launches Industry-First Large-Volume Plunger
21.01.BD and Ypsomed Develop 5.5mL Syringe Variant in Expansion of Partnership
21.01.Ember LifeSciences Taps Former Amgen Exec as CFO
21.01.Daiichi Sankyo Opens New Toronto HQ
21.01.Odyssey Therapeutics Appoints Jolie Siegel EVP and General Counsel
21.01.Crystalys Therapeutics Taps Justin Thacker as CFO
21.01.Charles River, Gazi University Partner to Develop Advanced Therapies
21.01.Vetter Affirms Strategic Commitment to Sustainability
20.01.Worldwide Clinical Trials to Acquire Catalyst Clinical Research
20.01.Alteogen, Tesaro Agree to Develop Subcutaneous Form of Dostarlimab